ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network

Finne, P; Finne, R; Auvinen, A; Juusela, H; Aro, J; Mttnen, L; Hakama, M; Rannikko, S; Tammela, TLJ; Stenman, UH
Urology2000-9DOI: 10.1016/S0090-4295(00)00672-5
121被引7阅读
引用收藏
分享

摘要

Objectives. To assess whether an artificial neural network (multilayer perceptron, MLP) and logistic regression (LR) could eliminate more false-positive prostate-specific antigen (PSA) results than the proportion of free: PSA in a prostate cancer screening. Methods. MLP and LR models were constructed on the basis of data on total PSA, the proportion of free PSA, digital rectal examination (DRE), and prostate volume from 656 consecutive men (aged 55 to 67 years) with total serum PSA concentrations of 4 to 10 ng/mL in the randomized population-based prostate cancer screening study in Finland. The MLP and LR models were validated using the "leave-one-out" method. Results. Of the 656 men, 23% had prostate cancer and 77% had either normal prostatic histology or a benign disease. At a 95% sensitivity level, 19% of the false-positive PSA results could be eliminated by using the proportion of free PSA versus 24% with the LR model and 33% with the MLP model (P < 0.001). At 80% to 99% sensitivity levels, the accuracy of the MLP and LR models was significantly higher than that of the proportion of free PSA. At 89% to 99% sensitivities, the accuracy of the MLP was higher than that of LR (P less than or equal to 0.001). Conclusions. At clinically relevant sensitivity levels, the MLP and LR models based on total PSA, the proportion of free PSA, DRE, and prostate volume could reduce the number of unnecessary biopsies significantly better than the proportion of free PSA alone in men with total PSA levels in the range 4 to 10 ng/mL. UROLOGY 56: 418-422, 2000.

学科与关键词

关键词
ARTIFICIAL NEURAL NETWORKSANTIGEN PSACANCERSERUMAGEALPHA-1-ANTICHYMOTRYPSINPROBABILITYCOMPLEXVOLUME
相关
加载中…
  • PSA and new biomarkers within multivariate models to improve early detection of prostate cancer
    Stephan, Carsten*; Cammann, Henning; Meyer, Hellmuth-A.; Lein, Michael; Jung, KlausCancer Letters, 2007, 249(1): 18-29.被引 52
  • The problem of cutoff levels in a screened population - Appropriateness of informing screenees about their risk of having prostate carcinoma
    Horninger, W; Bartsch, G; Snow, PB; Brandt, JM; Partin, AWCancer, 2001, 91(8): 1667-1672.被引 20
  • The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone:: A systematic review
    Schroder, Fritz; Kattan, Michael W.European Urology, 2008, 54(2): 274-290.被引 112
查看全部 →

发表信息

论文状态
公开发表
期刊
Urology
发表日期
2000-09
卷期
第 56 卷, 第 3 期
页码
418-422
DOI
10.1016/S0090-4295(00)00672-5
语言
ENGLISH
成果收录
SCIE

作者

  • F

    Finne, P (第一作者)

  • F

    Finne, R

查看全部 10 位作者收起作者
  • A

    Auvinen, A

  • J

    Juusela, H

  • A

    Aro, J

  • M

    Mttnen, L

  • H

    Hakama, M

  • R

    Rannikko, S

  • T

    Tammela, TLJ

  • S

    Stenman, UH

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417